Skip to main content
. Author manuscript; available in PMC: 2013 Oct 21.
Published in final edited form as: Semin Thromb Hemost. 2012 Oct 30;38(8):845–853. doi: 10.1055/s-0032-1328894

Fig. 2.

Fig. 2

A, Cases per year of thienopyridine-associated thrombotic thrombocytopenic purpura (TTP) reported to the U.S. Food and Drug Administration (FDA) (1998–2011). B, Drugs and number of cases reported to the FDA’s Adverse Event Reporting System in association with thrombotic thrombocytopenic purpura (1998–2011).